Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor
Clinical trial NCT04366648 · COMPLETED
Trial details
- NCT number
- NCT04366648
- Sponsor
- JenKem Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-04
- Primary completion
- 2021-03-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.